. . . . . "CAMZYOS" . . . "hypertrophic" . . . "™" . . . "HCM" . . . "obstructive hypertrophic cardiomyopathy" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "2022-10-11T09:30:02.005341"^^ . . "CAMZYOS™ is indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms. CAMYOS was indicated for adults with. symptomatic. New York. Heart Association class II and III obstructive. hypertrophic. hypertrophrophyopathy." . "2.3.0" . "RSA" . "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEApdULbl+/+pkVlq0fAzWmzfgIb+XMuQPKHMDVzUTWCZBjLfzORll42ptr52e4w7tTYkUKrBsQbx8lkjZWAlWiyh+xIK0oLFSdYRSt63kgiyRYBUOR+spcgmofb7f6JyftArPVTKhsWOMt/mcyNG9qc3lw8B/xuPmLteUWO33xWhfXQreTw1lsGUkZ1j4cB4X9HIuI20ktLYLCXaBauNHEJZ4qp6/Q2ATsJcw8tg7aRmFKXhrjM9maZ2+0cMg0Jpmn2UnDlPKXEA6Qq+qnvvQt8KFjIzP9FTMyvrWl8tTd0NCmS9VpooZJQ8We1lGMPXg5bMbe/bVkTf70fbFMf0RKrQIDAQAB" . "fegq/Asx9Gi6GG7pCrJBqW0MC9cTCOH4fT5NT7jDSuFyvzRs6XKaK9WC9QZVmyJ1XQyW5/0QnJmFVAcENdP1GnPe5HKQ/tEOS6+scC4oE6gzsV8GxPWKbSJPAtjNJMlKsB3M6CsIl7TVvWZ4MiDzWxX5dfUc/llMouUkoTozTdkbSFzp17ZrFcl0q1HVaQ4ndh+pDWZz/PD4rKbAOZNidWgvfzYwcJoVUJQ52Lxrg8UQwXJmyU5UMTRoj44uEVkn3u9wieW+Su4oeRIC/cN22grfD0Km6kGEsz3Anmw4MamF9t/qo3kmJgt0RVpPcZKKBjc2a/l3K7ffBd/I8A6X0A==" . . "2022-10-11T09:30:02.005341"^^ . .